Towards Healthcare
Mass Spectrometry Market to Rise USD 12.44 Bn by 2034

Mass Spectrometry Market 2025 Advances with Portable MS Adoption

Projections indicate that, the global mass spectrometry market will increase from USD 6.24 billion in 2024 to USD 12.44 billion by 2034, experiencing a CAGR of 7.14% over the next 10 years. Rising demand in pharmaceutical and biotechnology research has driven the growth of the market. North America led the global market owing to the strong presence of leading pharmaceutical and biotechnology companies.

Content

  • Insight Code: 6152
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The mass spectrometry market is worth USD 6.69 billion in 2025, and by 2034, it is forecasted to hit USD 12.44 billion, registering a CAGR of 7.14% over the decade.

North America is leading the mass spectrometry market share 40% due to the growing clinical trial activity, increasing investments, and the presence of key players.

The Mass Spectrometry market includes 8 segments including by cytokine type, by application, by source, by host expression system, by end-user, by formulation, by packaging size, and by region.

Some key players include Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, SCIEX, Bruker Corporation and Shimadzu Corporation among others

Key trends include the Miniaturization and Portability of Instruments, advancements in ionization techniques, and advancements in instrumentation and ion sources.

American Society for Mass Spectrometry, Indian Society for Mass Spectrometry (ISMAS), Government of Canada, British Mass Spectrometry Society (BMSS), Food and Drug Administration, clinicaltrials.gov, MSACL - Mass Spectrometry & Advances in the Clinical Lab, GOV.UK
Any Questions